Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alnylam Pharmaceuticals (DE:DUL)
FRANKFURT:DUL
Holding DE:DUL?
Track your performance easily
Alnylam Pharma (DUL) Ownership Overview
0.37% Insiders
48.38% Mutual Funds
31.12% Other Institutional Investors
15.30% ETFs
4.82% Public Companies and
Individual Investors
The ownership structure of Alnylam Pharma (DE:DUL) stock is a mix of institutional, retail, and individual investors. Approximately 94.80% of the company’s stock is owned by Institutional Investors, 0.37% is owned by Insiders, and 4.82% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 26, 2024 | Pushkal Garg Cmo & Evp Dev & Med Affairs | xxxxxxxxxxxxx | $485773 |
| Jun 26, 2024 | Yvonne Greenstreet Ceo,director | xxxxxxxxxxxxx | $1917475 |
| Jun 26, 2024 | Fitzgerald Kevin Joseph Cso & Evp, Head Of Research | xxxxxxxxxxxxx | $276731 |
| Jun 26, 2024 | Jeffrey V. Poulton Evp & Cfo | xxxxxxxxxxxxx | $370747 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $602640 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $3216591 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $7894827 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $8996346 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,034,541 | Institution | 9.33% | 3,307,079,832 | |
| 11,130,048 | Institution | 8.63% | 3,058,526,060 | |
| 10,609,427 | Institution | 8.23% | 2,915,459,930 | |
| 4,927,057 | Institution | 3.82% | 1,353,950,337 | |
| 4,161,874 | Institution | 3.23% | 1,143,678,813 | |
| 3,622,535 | Institution | 2.81% | 995,468,995 | |
| 3,424,200 | Institution | 2.65% | 940,966,736 | |
| 2,953,386 | Institution | 2.29% | 811,587,519 | |
| 2,850,341 | Institution | 2.21% | 783,270,856 | |
| 2,429,100 | Institution | 1.88% | 667,514,251 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,130,048 | Institution | 8.63% | 3,058,526,060 | |
| 10,609,427 | Institution | 8.23% | 2,915,459,930 | |
| 4,927,057 | Institution | 3.82% | 1,353,950,337 | |
| 3,424,200 | Institution | 2.65% | 940,966,736 | |
| 2,953,386 | Institution | 2.29% | 811,587,519 | |
| 2,850,341 | Institution | 2.21% | 783,270,856 | |
| 2,429,100 | Institution | 1.88% | 667,514,251 | |
| 2,331,102 | Institution | 1.81% | 640,584,498 | |
| 1,705,722 | Institution | 1.32% | 468,730,700 | |
| 1,524,500 | Institution | 1.18% | 418,931,076 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Alnylam Pharmaceuticals (DE:DUL)?
According to the latest TipRanks data, approximately 31.12% of the company's stock is held by institutional investors, 0.37% is held by insiders, and 4.82% is held by retail investors.
What percentage of Alnylam Pharmaceuticals (DE:DUL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.12% of Alnylam Pharmaceuticals (DE:DUL) stock is held by institutional investors.
What percentage of Alnylam Pharmaceuticals (DE:DUL) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.82% of Alnylam Pharmaceuticals (DE:DUL) stock is held by retail investors.
Who owns the most shares of Alnylam Pharmaceuticals (DE:DUL)?
Vanguard owns the most shares of Alnylam Pharmaceuticals (DE:DUL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.